Sanofi-Pasteur
Sanofi and Translate Bio expand mRNA vaccine agreement
Richard Staines
COVID-19, infectious diseases, R&D, Sanofi-Pasteur, Translate Bio, vaccine
0 Comment
News/ News/ News/ News/ Oncology/ R&D/ Sales and Marketing
David Loew swaps Sanofi’s top vaccine job for CEO role at Ipsen
Phil Taylor
appointment, Ipsen, Sanofi-Pasteur, senior management
0 Comment
Sanofi inks COVID-19 mRNA vaccine deal with Translate Bio
Richard Staines
coronavirus, COVID-19, R&D, Sanofi-Pasteur, Translate Bio, vaccine
0 Comment
Sanofi invests in new Canadian vaccine manufacturing plant
Richard Staines
manufacturing, Sanofi, Sanofi-Pasteur, vaccines
0 Comment
Regeneron ends development of RSV antibody
Richard Staines
AstraZeneca, infectious diseases, R&D, Regeneron, respiratory syncytial virus, Sanofi-Pasteur
0 Comment
Regeneron dumps suptavumab after phase 3 trial failure.
Sanofi beats expectations, driven by rare diseases and vaccines
Richard Staines
Dupixent, Genzyme, Lantus, Sanofi, Sanofi-Pasteur
0 Comment
But sales of key insulin fall amid biosimilar competition.
Sanofi to repay US government $19.8 million
Richard Staines
pricing, reimbursement, Sanofi, Sanofi-Pasteur
0 Comment
Costly accounting error for Sanofi.